Detalhe da pesquisa
1.
Transient Receptor Potential Vanilloid-1 Channels Facilitate Axonal Degeneration of Corneal Sensory Nerves in Dry Eye.
Am J Pathol
; 194(5): 810-827, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38325553
2.
An ocular Th1 immune response promotes corneal nerve damage independently of the development of corneal epitheliopathy.
J Neuroinflammation
; 20(1): 120, 2023 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37217914
3.
Venetoclax-resistant CLL cells show a highly activated and proliferative phenotype.
Cancer Immunol Immunother
; 71(4): 979-987, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34467417
4.
Transient tear hyperosmolarity disrupts the neuroimmune homeostasis of the ocular surface and facilitates dry eye onset.
Immunology
; 161(2): 148-161, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32702135
5.
Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia.
Cancer Immunol Immunother
; 69(5): 813-824, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32055920
6.
Chronic lymphocytic leukemia cells increase neutrophils survival and promote their differentiation into CD16high CD62Ldim immunosuppressive subset.
Int J Cancer
; 144(5): 1128-1134, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30178523
7.
LPL protein in Chronic Lymphocytic Leukaemia have different origins in Mutated and Unmutated patients. Advances for a new prognostic marker in CLL.
Br J Haematol
; 182(4): 521-525, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29953583
8.
Mucosal immune tolerance at the ocular surface in health and disease.
Immunology
; 150(4): 397-407, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28108991
9.
Neutrophils from chronic lymphocytic leukemia patients exhibit an increased capacity to release extracellular traps (NETs).
Cancer Immunol Immunother
; 66(1): 77-89, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27796477
10.
The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients.
Cancer Immunol Immunother
; 66(4): 461-473, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28011996
11.
Mucosal tolerance disruption favors disease progression in an extraorbital lacrimal gland excision model of murine dry eye.
Exp Eye Res
; 151: 19-22, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27443502
12.
The expression of sphingosine-1 phosphate receptor-1 in chronic lymphocytic leukemia cells is impaired by tumor microenvironmental signals and enhanced by piceatannol and R406.
J Immunol
; 193(6): 3165-74, 2014 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25127862
13.
Expression and function of cathelicidin hCAP18/LL-37 in chronic lymphocytic leukemia.
Haematologica
; 105(9): e465-469, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33054065
14.
Second generation BTK inhibitors impair the anti-fungal response of macrophages and neutrophils.
Am J Hematol
; 95(7): E174-E178, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32267009
15.
Galectins in hematological malignancies.
Curr Opin Hematol
; 20(4): 327-35, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23695449
16.
CXCL12 is a costimulator for CD4+ T cell activation and proliferation in chronic lymphocytic leukemia patients.
Cancer Immunol Immunother
; 62(1): 113-24, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22842611
17.
Autologous T-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies.
Haematologica
; 103(10): e458-e461, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29748439
18.
The protective role of the microenvironment in hairy cell leukemia treatment: Facts and perspectives.
Front Oncol
; 13: 1122699, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36968995
19.
Venetoclax resistance induced by activated T cells can be counteracted by sphingosine kinase inhibitors in chronic lymphocytic leukemia.
Front Oncol
; 13: 1143881, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37020867
20.
High expression of AID and active class switch recombination might account for a more aggressive disease in unmutated CLL patients: link with an activated microenvironment in CLL disease.
Blood
; 115(22): 4488-96, 2010 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-20233972